跳至主要内容
临床试验/NCT03784495
NCT03784495已完成不适用

Is a Combination of Melatonin and Aminoacids Useful to Sarcopenic Elderly Patients? A Randomized Trial

Azienda di Servizi alla Persona di Pavia1 个研究点 分布在 1 个国家目标入组 159 人开始时间: 2014年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
159
试验地点
1
主要终点
Change in Handgrip Strenght

研究概览

简要总结

To evaluate the effectiveness of melatonin and essential aminoacid supplementation on body composition, protein metabolism, strength and inflammation. The investigators performed a Randomized controlled parallel groups preliminary trial in 159 elderly sarcopenic people (42/117 men/women) assigned to 4 groups: isocaloric placebo (P, n=44), melatonin (M, 1 mg/daily, n=42,), essential aminoacids (eAA 4 g/daily, n=40) or eAA plus melatonin (eAAM, 4 g eAA and 1 mg melatonin/daily, n= 30). The period of intervention was 4 weeks. Data from body composition (DXA), strength (handgrip test) and biochemical parameters for the assessment of protein metabolism (albumin) and inflammation (PRC) were collected at baseline and after the 4-week intervention

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged > or equal 65 years
  • Sarcopenic patients, following the Rosetta Study criteria: Skeletal Muscle Index [SMI] was <7.23 kg/m2 in men and <5.45 kg/m2 in women) and loss of strength, evaluated by dynamometer and defined as <30 kg for men and <20 kg for women, using the average value of the two handgrip measurements of the dominant hand.

排除标准

  • acute illnesses
  • severe liver dysfunction
  • severe heart dysfunction
  • severe kidney dysfunction
  • severe dementia
  • uncontrolled diabetes
  • dysthyroidism
  • any endocrinopathies
  • neoplasia
  • patients treated with steroids
  • patients entirely unable to walk

研究组 & 干预措施

Placebo (P)

Placebo Comparator

Placebo.

干预措施: Placebo (Other)

Melatonin (M)

Experimental

1 mg/day of melatonin.

干预措施: Melatonin 1mg (Drug)

Essential Aminoacids (eAA)

Experimental

4 g/day of essential aminoacids

干预措施: Essential Aminoacids (eAA) (Dietary Supplement)

Essential Aminoacids + Melatonin (eAAM)

Experimental

4 g/day of essential aminoacids and 1 mg/day of melatonin

干预措施: Essential Aminoacids + melatonin (Combination Product)

结局指标

主要结局

Change in Handgrip Strenght

时间窗: 0, 30 days

Handgrip strength assessed using a Jamar dynamometer adhering to the standardized protocol recommended by the American Society of Hand Therapists. A weak handgrip was defined as \<30 kg for men and \<20 kg for women, based on the average value of the two handgrip measurements of the dominant hand

Change in Total Fat Mass and Total Free Fat Mass (DXA)

时间窗: 0, 30 days

Body composition by dual-energy X-ray absorptiometry (DXA). Body composition was measured by DXA, using a Lunar Prodigy DXA (GE Medical Systems, Waukesha, WI). Free Fat mass and Fat mass of specific body regions were measured in kilograms.

次要结局

  • Height(At baseline (0))
  • Change in erythrocyte sedimentation rate (ESR)(0, 30 days)
  • Change in dietary intake(Measures taken at day 1,2,3 and at day 28,29,30)
  • Change in Body Weight(0, 30 days)
  • Change in blood lipids (total cholesterol and triglycerides)(0, 30 days)
  • Change in High-sensitivity C-reactive protein (CRP)(0, 30 days)
  • Change in glycaemia(0, 30 days)
  • Change in serum proteins(0, 30 days)
  • Change in Mini Nutritional Assessment (MNA)(0, 30 days)

研究者

发起方
Azienda di Servizi alla Persona di Pavia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mariangela Rondanelli

MD, Associate Professor

Azienda di Servizi alla Persona di Pavia

研究点 (1)

Loading locations...

相似试验